OR WAIT null SECS
Senior Director, Therapeutic Strategy Lead, Rare Disease, Worldwide Clinical Trials
May 16, 2023
Stakeholders must alter their mindsets when it comes to early-phase design and interpreting regulatory guidance for CGT trials.